Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 43% ± 25% | |
ciliated cell | 9 studies | 21% ± 7% | |
astrocyte | 9 studies | 28% ± 12% | |
GABAergic neuron | 8 studies | 38% ± 24% | |
fibroblast | 8 studies | 19% ± 3% | |
endothelial cell | 7 studies | 32% ± 14% | |
oligodendrocyte precursor cell | 6 studies | 28% ± 12% | |
neuron | 4 studies | 27% ± 10% | |
granule cell | 4 studies | 33% ± 12% | |
retinal ganglion cell | 4 studies | 29% ± 9% | |
epithelial cell | 4 studies | 18% ± 3% | |
interneuron | 4 studies | 40% ± 25% | |
amacrine cell | 3 studies | 29% ± 5% | |
GABAergic interneuron | 3 studies | 19% ± 3% | |
myofibroblast cell | 3 studies | 26% ± 7% | |
adipocyte | 3 studies | 18% ± 3% | |
smooth muscle cell | 3 studies | 18% ± 2% | |
oligodendrocyte | 3 studies | 24% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 33% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 21758.53 | 1420 / 1445 | 100% | 18.86 | 183 / 183 |
skin | 100% | 12637.65 | 1802 / 1809 | 98% | 11.12 | 464 / 472 |
prostate | 100% | 16996.54 | 244 / 245 | 97% | 9.68 | 487 / 502 |
breast | 99% | 11478.56 | 456 / 459 | 97% | 9.25 | 1079 / 1118 |
intestine | 99% | 21792.11 | 958 / 966 | 97% | 8.92 | 509 / 527 |
ovary | 100% | 17921.00 | 180 / 180 | 94% | 10.11 | 406 / 430 |
brain | 93% | 43867.91 | 2464 / 2642 | 99% | 20.92 | 699 / 705 |
uterus | 99% | 25476.14 | 169 / 170 | 93% | 9.52 | 426 / 459 |
lung | 98% | 10840.80 | 567 / 578 | 94% | 8.66 | 1087 / 1155 |
bladder | 100% | 18962.19 | 21 / 21 | 90% | 6.16 | 453 / 504 |
stomach | 92% | 12696.81 | 331 / 359 | 97% | 11.87 | 278 / 286 |
thymus | 99% | 8729.86 | 645 / 653 | 90% | 5.28 | 544 / 605 |
adrenal gland | 91% | 6975.16 | 234 / 258 | 97% | 29.64 | 223 / 230 |
kidney | 81% | 5164.96 | 72 / 89 | 96% | 7.77 | 863 / 901 |
pancreas | 64% | 3633.45 | 210 / 328 | 97% | 8.64 | 173 / 178 |
liver | 47% | 2493.20 | 107 / 226 | 69% | 3.41 | 279 / 406 |
muscle | 100% | 20380.70 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.32 | 1 / 1 |
blood vessel | 100% | 33323.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 8055.36 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 11595.44 | 1196 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 9.23 | 79 / 80 |
heart | 97% | 11709.95 | 833 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 8.60 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 66% | 3.78 | 19 / 29 |
peripheral blood | 17% | 1020.58 | 159 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0072164 | Biological process | mesonephric tubule development |
GO_0006611 | Biological process | protein export from nucleus |
GO_0021510 | Biological process | spinal cord development |
GO_0001701 | Biological process | in utero embryonic development |
GO_0090162 | Biological process | establishment of epithelial cell polarity |
GO_0048754 | Biological process | branching morphogenesis of an epithelial tube |
GO_0007507 | Biological process | heart development |
GO_0072205 | Biological process | metanephric collecting duct development |
GO_0001892 | Biological process | embryonic placenta development |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0072177 | Biological process | mesonephric duct development |
GO_0050982 | Biological process | detection of mechanical stimulus |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0001822 | Biological process | kidney development |
GO_0034405 | Biological process | response to fluid shear stress |
GO_0001889 | Biological process | liver development |
GO_0072237 | Biological process | metanephric proximal tubule development |
GO_0160040 | Biological process | mitocytosis |
GO_0048806 | Biological process | genitalia development |
GO_0072218 | Biological process | metanephric ascending thin limb development |
GO_0072287 | Biological process | metanephric distal tubule morphogenesis |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0060674 | Biological process | placenta blood vessel development |
GO_0051290 | Biological process | protein heterotetramerization |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0048565 | Biological process | digestive tract development |
GO_0060428 | Biological process | lung epithelium development |
GO_0036303 | Biological process | lymph vessel morphogenesis |
GO_0060236 | Biological process | regulation of mitotic spindle organization |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0001502 | Biological process | cartilage condensation |
GO_0043588 | Biological process | skin development |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0021915 | Biological process | neural tube development |
GO_0007161 | Biological process | calcium-independent cell-matrix adhesion |
GO_0051216 | Biological process | cartilage development |
GO_0006816 | Biological process | calcium ion transport |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0061136 | Biological process | regulation of proteasomal protein catabolic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0031514 | Cellular component | motile cilium |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0060170 | Cellular component | ciliary membrane |
GO_0009986 | Cellular component | cell surface |
GO_0000139 | Cellular component | Golgi membrane |
GO_0140494 | Cellular component | migrasome |
GO_0005929 | Cellular component | cilium |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0034704 | Cellular component | calcium channel complex |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0002133 | Cellular component | polycystin complex |
GO_0030660 | Cellular component | Golgi-associated vesicle membrane |
GO_0034703 | Cellular component | cation channel complex |
GO_0005634 | Cellular component | nucleus |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0042813 | Molecular function | Wnt receptor activity |
GO_0005261 | Molecular function | monoatomic cation channel activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005515 | Molecular function | protein binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | PKD1 |
Protein name | Polycystin 1, transient receptor potential channel interacting Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein) PC-1 mutant (Polycystic kidney disease 1) Polycystic kidney disease-associated protein PKD1 Polysystin 1 |
Synonyms | pkd1 |
Description | FUNCTION: Component of a heteromeric calcium-permeable ion channel formed by PKD1 and PKD2 that is activated by interaction between PKD1 and a Wnt family member, such as WNT3A and WNT9B . Both PKD1 and PKD2 are required for channel activity . Involved in renal tubulogenesis . Involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (By similarity). Acts as a regulator of cilium length, together with PKD2 (By similarity). The dynamic control of cilium length is essential in the regulation of mechanotransductive signaling (By similarity). The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases flow-induced signaling (By similarity). May be an ion-channel regulator. Involved in adhesive protein-protein and protein-carbohydrate interactions. Likely to be involved with polycystin-1-interacting protein 1 in the detection, sequestration and exocytosis of senescent mitochondria . . |
Accessions | ENST00000488185.2 H3BTG3 H3BSE9 I3L4N0 H3BTE0 Q15142 ENST00000483024.1 C1JFL7 H3BV77 O75276 ENST00000568591.5 C1JFL5 ENST00000561668.5 ENST00000487932.5 ENST00000262304.9 [P98161-1] A0A097HUC6 H3BSE8 P98161 H3BQF4 C1JFL6 ENST00000423118.5 [P98161-3] A0A867GBE4 ENST00000562425.1 ENST00000567946.1 |